Eltrombopag: the discovery of a second generation thrombopoietin-receptor agonist

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.4, Iss.1, 2009-01, pp. : 85-93

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Balaglitazone: A Second Generation Peroxisome Proliferator-Activated Receptor (PPAR) Gamma (&ggr;) Agonist

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 2, 2012-02 ,pp. : 87-97

Bentham Science Publishers

Access to resources Recommend Favorite

Eltrombopag

By Garnock-Jones Karly P. Keam Susan J.

Drugs, Vol. 69, Iss. 5, 2009-03 ,pp. : 567-576

Adis International

Access to resources Recommend Favorite

Palonosetron: a second generation 5-hydroxytryptamine 3 receptor antagonist

By Navari Rudolph M

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 12, 2009-12 ,pp. : 1577-1586

Informa Healthcare

Access to resources Recommend Favorite

Agonist-specific receptor conformations

By Kenakin T.

Trends in Pharmacological Sciences, Vol. 18, Iss. 11, 1997-11 ,pp. : 416-417

Elsevier

Access to resources Recommend Favorite

Lead generation and lead optimisation approaches in the discovery of selective, non-peptide ORL-1 receptor agonists and antagonists

By Ronzoni S. Peretto I. Giardina G.A.

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 4, 2001-04 ,pp. : 525-546

Informa Healthcare

Access to resources Recommend Favorite